Coumadin aspirin reinfarction study: Rationale and design of the CARS study

Journal of Thrombosis and Thrombolysis: An International Journal for Clinicians and Scientists

Volumn 2, Issue 3, 1995, Pages 171-176

  Vorchheimer, David A ^a   Fuster, Valentin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

antithrombotic therapy; aspirin; Coumadin; myocardial infarction; randomized clinical trial; warfarin

Indexed keywords

EID: 0010402053     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/BF01062707     Document Type: Article

References (37)

1. Antithrombin agents in coronary artery disease
2. Factors influencing the presence or absence of acute coronary thrombi in sudden ischemic death
3. Coronary artery disease progression and acute coronary syndromes
4. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
5. An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall [abstract]
6. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease
7. Thrombin generation as an acute effect of cigarette smoking
8. Cardiovascular and thrombosis pathology associated with cocaine use
9. Fibrinogen as a risk factor for stroke and myocardial infarction
10. Haemostatic function and ischemie heart disease: Principal results of the Northwick Park Heart Study
11. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
12. Aspirin as a therapeutic agent in cardiovascular disease. AHA medical/scientific statement. Circulation 1993;87: 659–675.
13. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
14. Aspirin in coronary heart disease
15. Aspirin and secondary mortality after myocardial infarction
16. The German-Austrian Aspirin Trial: A comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction
17. The Aspirin Myocardial Infarction Study: Final results
18. Persantine and aspirin in coronary heart disease
19. Persantine-aspirin study. II. Secondary coronary prevention with persantine and aspirin
20. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
21. Antithrombotic agents in coronary artery disease
22. Long-term anticoagulant therapy after myocardial infarction: Final report of the Veteran's Administration Cooperative Study
23. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction
24. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction
25. The effect of warfarin on mortality and reinfarction after myocardial infarction
26. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction
27. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
28. Platelet aggregation, coronary artery disease progression and future coronary events
29. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction; ISIS-2
30. Combination antithrombotic therapy in unstable rest angina and non-Q wave infarction in nonprior aspirin users: Primary end points analysis from the ATACS trial
31. A comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement
32. Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation